Hepion Striving to Repeat History by Developing its Second FDA-Approved Drug
March 22, 2021 at 12:12 PM EDT
Hepion Pharmaceuticals (NASDAQ: HEPA) is one of the sponsors for the Benzinga Biotech Global Small Cap Conference taking place on March ...